We are live on ! Find out more
NVNO

enVVeno Medical

36 hedge funds and large institutions have $17.5M invested in enVVeno Medical in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

964% more call options, than puts

Call options by funds: $383K | Put options by funds: $36K

57% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 7

38% more funds holding

Funds holding: 2636 (+10)

1% more capital invested

Capital invested by funds: $17.3M → $17.5M (+$234K)

0.41% more ownership

Funds ownership: 0.71%1.12% (+0.41%)

Holders
36
Holders Change
+10
Holders Change %
+38.46%
% of All Funds
0.52%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
11
Reduced
7
Closed
Calls
$383K
Puts
$36K
Net Calls
+$347K
Net Calls Change
-$1.26M

NVNO Hedge Fund Activity: Q3 2024 in Review

36 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q3 2024, worth a combined $17.5M — up 1.4% from $17.3M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new NVNO positions and 0 closed out — a net gain of 10 holders — while 11 added to existing stakes and 7 trimmed.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $2.23M. The largest seller was Laird Norton Wetherby Trust Company, cutting an estimated $42.1K.

  • 36 institutional investors held enVVeno Medical (NVNO) as of Q3 2024, up from 26 in Q2 2024.
  • Funds reported $17.5M of enVVeno Medical stock for Q3 2024, up 1.4% quarter-over-quarter.
  • 10 funds opened new enVVeno Medical positions in Q3 2024 and 0 closed out, a net change of +10 holders.
  • The largest enVVeno Medical buyer in Q3 2024 was Alyeska Investment Group, an estimated $2.23M added.
  • The largest enVVeno Medical seller in Q3 2024 was Laird Norton Wetherby Trust Company, an estimated $42.1K sold.

Based on aggregated 13F filings for Q3 2024.